• Home
  • Media
  • Press Releases

Press Releases

AED 497.8 million the total profit of Julphar for the second quarter

2015-08-20
Julphar announced sales revenue worth AED 799.5 million in the first half of this year, with a growth of 5% compared to the same period of 2014. The company’s financial results, which were shared…

A new milestone for Julphar’s insulin glargine

2015-05-22
Julphar announced today that it reached a new milestone for the recombinant Insulin Glargine.   In collaboration with one of the leading biopharmaceutical R&D companies in Europe, Julphar succeeded…

AED 226.7 million the total profit of Julphar for the first quarter

2015-05-17
Julphar announced unified sales revenue for the first quarter of this year worth AED 397.6 million, with a growth of 1.1% compared to the same period of 2014. The company’s financial results, which…

Julphar successfully concludes Phase I clinical trial of its biosimilar human insulin

2015-04-29
Julphar today announced its Phase 1 clinical data that demonstrated similarity of its investigational biosimilar human insulin compared to the EU-licensed reference product, Eli Lilly HUMINSULIN®.…
This website intends to use cookies to improve the site and your experience. By continuing to browse the site you are agreeing to accept our use of cookies. If you require further information and/or do not wish to have cookies placed when using the site, refer to our Cookie Policy.